Related Experiment Video

Updated: May 5, 2026

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

2.4K

Rethinking Mitochondrial Parkinson's Disease in the α-Synuclein Seed Amplification Assays Era

Marco Percetti1,2, Vidal Yahya1,2, Alessio Di Fonzo1

  • 1Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Neurology Unit, Milan, Italy.

Movement Disorders : Official Journal of the Movement Disorder Society
|May 4, 2026
PubMed
Summary

No abstract available in PubMed .

More Related Videos

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
15:09

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

16.2K
Author Spotlight: Decoding Mitochondrial Aging
08:48

Author Spotlight: Decoding Mitochondrial Aging

Published on: June 30, 2023

6.3K

Related Experiment Videos

Last Updated: May 5, 2026

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

2.4K
The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
15:09

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

16.2K
Author Spotlight: Decoding Mitochondrial Aging
08:48

Author Spotlight: Decoding Mitochondrial Aging

Published on: June 30, 2023

6.3K

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

28
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28

Articles linked to this work by shared authors, journal, and citation graph.

Age-Specific Parkinson Disease Risk in Gaucher Disease Type 1: Data From the ICGG Gaucher Registry.

Neurology·2026

Sex Differences in Levodopa-Sparing Effect of Safinamide: Post-hoc Findings from a Multicenter, Longitudinal, Case-Control Study.

Movement disorders clinical practice·2026

Variants in the proteasome regulator PSMF1 cause a phenotypic spectrum from parkinsonism to perinatal lethality.

Nature communications·2026

CACNA1C -Related Channelopathy Presenting With Adult-Onset Combined Dystonia-Parkinsonism: A Novel Neurological Presentation.

American journal of medical genetics. Part A·2026

Metabolomics of Multiple System Atrophy Patient-Derived Striatal Medium Spiny Neurons.

Biomolecules·2026

Clinical and Genotypic Spectrum of Twinkle-Related Disorders: Insights From a Multinational Cohort Study.

Neurology·2026

Apathy in Lewy Body Disorders: A Position Paper.

Movement disorders : official journal of the Movement Disorder Society·2026

Subthalamic Nucleus Deep Brain Stimulation Enhanced Long-Latency Reflex II in Parkinson's Disease Through Rapid Subthalamic-Cortical Modulation.

Movement disorders : official journal of the Movement Disorder Society·2026

Joint Risk Factor Combinations with Additive Interaction Increase the Risk of Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026

COVID-19 Amplifies Sex-Specific Dopamine and Glial Responses in a Parkinson's Disease Mouse Model.

Movement disorders : official journal of the Movement Disorder Society·2026

Early Longitudinal Brain Network Changes in Huntington's Disease Before Clinical Motor Onset.

Movement disorders : official journal of the Movement Disorder Society·2026

Expanded ATXN3 CAG Repeat is Stable in Human Purkinje Cells.

Movement disorders : official journal of the Movement Disorder Society·2026

Cross-species R-DeeP profiling reveals a conserved core of RNA-dependent proteins in yeast.

Nucleic acids research·2026

Growth, signals, and survival: the evolutionary divergence of terpenoid metabolism in terrestrial plants.

Natural product reports·2026

Complete mitochondrial genome of Meganola major (Hampson, 1891) (Lepidoptera: Nolidae).

Mitochondrial DNA. Part B, Resources·2026

Exploring the concept of longevity in fungi.

Trends in microbiology·2026

Trade-offs between photosynthetic capacity and structural economy underlie the rapid proliferation of floating Ulva prolifera.

Harmful algae·2026

Daily Variations in the Total Antioxidant Status, Nuclear Melatonin Receptor RORα, and Nuclear Factor NF-ƙβ in the Lymphoid Organs of a Seasonally Breeding Tropical Squirrel, Funambulus pennanti.

Journal of experimental zoology. Part A, Ecological and integrative physiology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us